Nitec: Lodotra Works in Late-Stage Arthritis Study

Privately owned Swiss biotech firm Nitec said its Lodotra drug proved effective in a late-stage trial of patients with rheumatoid arthritis and it will use the data to apply for U.S. approval.
CNBC